Online Database of Chemicals from Around the World 产品搜索 | 产品提交 | 产品推广

网站主页 >> 化工产品目录 >> Vidofludimus>> 市场分析报告
 

Vidofludimus市场分析报告

Primary Sclerosing Cholangitis– Pipeline Insight, 2020
... -838 is a small molecule investigational drug (vidofludimus calcium) under development as an oral tablet ... , thereby reducing inflammation. In preclinical studies of vidofludimus, the active moiety and free ...

2020 COVID-19 Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
... , Vazegepant , Velpatasvir, Veru-111, Videsil, Vidofludimus calcium, Virazole, VPM1002, XAV-19, XC221 ...

COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report- September 2020 Update
... , Vazegepant , Velpatasvir, Veru-111, Videsil, Vidofludimus calcium, Virazole, VPM1002, XAV-19, XC221 ...

Primary Sclerosing Cholangitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Primary Sclerosing Cholangitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Primary Sclerosing Cholangitis - Drugs ...




Copyright ©  chemBlink. 版权所有. 免责声明 | 网站简介 | 在线联系